Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients
Medical Xpress
MARCH 6, 2023
A one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) therapy by the University of Sydney did not lead to lower rates of skin cancer in organ transplant recipients.
Let's personalize your content